Document Detail


Assessment of vascular endothelial growth factor, basic fibroblast growth factor, and transforming growth factor levels in amniotic fluid.
MedLine Citation:
PMID:  23091987     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVE: To measure amniotic fluid levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor (TGF)-beta2 and to characterize their levels with respect to advancing gestational age and pregnancy-related complications.
STUDY DESIGN: Amniotic fluid was collected from a total of 37 patients, 2 of whom had twin pregnancies. Twenty-seven specimens were collected in the second trimester and 10 specimens were collected in the third trimester. VEGF, bFGF and TGF-beta2 were isolated from centrifuged amniotic fluid and quantified using commercially available ELISA kits. Concentrations of growth factors were expressed in pg/mL.
RESULTS: The growth factors under investigation were present in most but not all amniotic fluid specimens throughout pregnancy. The levels of VEGF, bFGF and TGF-beta2 were inconsistent and did not show a statistically significant association with gestational age, number of fetuses, or the presence of hypertension and/or diabetes. One significant finding emerged from the data: smokers had significantly higher amniotic fluid levels of VEGF compared to nonsmokers (p = 0.03).
CONCLUSION: VEGF, bFGF and TGF-beta2 are detectable in second and third trimester amniotic fluid. Smoking appears to correlate with increased amniotic fluid VEGF during pregnancy. VEGF may represent a molecular marker of hypoxia and is an interesting focus for future investigation.
Authors:
Mohamed A Bedaiwy; Janet M Burlingame; Mustafa Hussein; Rebecca Flyckt; Radwan Assad; Tommaso Falcone
Related Documents :
19250267 - Health outcomes of children fathered by patients treated with radioiodine for thyroid c...
24163697 - Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial jun...
12914727 - Management of hypo- and hyperthyroidism during pregnancy.
24950617 - Characterization of fetal growth by repeated ultrasound measurements in the wild guinea...
23971237 - Placental and umbilical cord macroscopic changes associated with fetal and maternal eve...
2158027 - Corticotropin-releasing factor and parturition: plasma and amniotic fluid levels and pl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  57     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:    2012 Sep-Oct
Date Detail:
Created Date:  2012-10-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  405-10     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio 44106, USA. bedaiwymmm@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiab...
Next Document:  Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia.